Results showed that four acyl-CoA synthetases—GCDH, ACSS2, ACOX1, and ACOX3—were significantly down-regulated in breast cancer cells, with ACSS2 showing the most pronounced reduction (Fig. 2D). The gene discussed is GCDH; the disease is breast carcinoma.